Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001466562-26-000007
Filing Date
2026-03-19
Accepted
2026-03-19 16:15:55
Documents
1
Period of Report
2026-03-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1773951351.html 4  
1 FORM 4 wk-form4_1773951351.xml 4 4672
  Complete submission text file 0001466562-26-000007.txt   6279
Mailing Address 101 FEDERAL STREET BOSTON MA 02110
Business Address 101 FEDERAL STREET BOSTON MA 02110 (888) 958-1253
ZEVRA THERAPEUTICS, INC. (Issuer) CIK: 0001434647 (see all company filings)

EIN.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O KARYOPHARM THERAPEUTICS INC. 85 WELLS AVENUE, SECOND FLOOR NEWTON MA 02459
Business Address
Renz Justin A (Reporting) CIK: 0001466562 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36913 | Film No.: 26774422